Insights
Insights From Our Experts
Articles
BLOG: Pharmaceutical Value-based Contracts: Adherence and Supportive Contracts
Posted by
Dr. Richard Stefanacci on July 20, 20217/20/21
While there is a great deal of talk regarding value-based contracts in the life sciences industry, there are few successful examples. The difficulties in structuring these contracts begin with identification of outcomes that are directly and…
The Patient Access Paradox: How the New CMS Rule Could Prioritize Drug Pricing Before Clinical Decision-Making
In January 2023, co-pay programs will be put to the test, consequently examining how well your brand can adapt to the Final Rule changes to meet patient and provider needs. Our recommendation: Don’t wait – start…
BLOG: Medical vs. Pharmacy Benefit: A Look at UM Differences
Posted by
Dr. Richard Stefanacci on July 1, 20217/1/21
Medicare medical and pharmacy benefits are very different in their utilization management (UM). As such, it is valuable to know the distinctions between benefits, as strategies differ depending on which ones apply. The most significant differentiator…
A SpaceX Philosophy to Launching in Pharma
In thinking about the economics around the launch of pharmaceutical products, it is useful to compare the situation to another area that has seen its economics evolve in recent years: space travel. For decades, the only…
Ask the Expert: One-on-One with Amy Hutnik
The pharma industry’s needs have evolved beyond one-dimensional playbooks, disconnected promotional efforts and limited ability to assess stakeholder engagement. Instead, manufacturers need to adopt a comprehensive omnichannel model that allows for data-driven planning and real-time analysis…
BLOG: Gaining Coverage for Emerging Medical Technologies
Posted by
Dr. Richard Stefanacci on June 15, 20216/15/21
The line between medical and personal care is everchanging. In all areas of our lives there is coverage through medical benefits, but the exact line between this and one’s personal responsibilities is not always as clear,…
Omnichannel: A Conversation With the Innovators
Go beyond marketing to provide actionable insights that better inform commercial strategies and elevate brand success. EVERSANA’s best-in-class omnichannel activation model aggregates and synthesizes pivotal datasets from marketing campaigns, patient services programs and field activities to analyze…
Pharma USA Webinar: Hot For Hybrid: Building Medical Field Teams For Healthcare’s New Normal
Posted on June 11, 20216/11/21
Hot For Hybrid: Building Medical Field Teams For Healthcare’s New Normal Featuring EVERSANA’s Marc Bernarducci, Senior Vice President of Field Solutions — Clinical This panel covers the following topics: Review the implications of new field force…
Pharma USA Webinars: Personalize HCP Experiences for Deeper Engagement
EVERSANA was proud to participate in two Pharma USA 2021 sessions. This webinar, featuring EVERSANA’s Amy Hutnik, General Manager, Agency, Advisory and Evidence Services, covers the following topics: Harnessing AI to inform your sales approach and…
Informing NAMs Payer Strategies and Improving Contracts With Integrated Commercial Services
Pharmaceutical manufacturers rely on national account managers (NAMs) to build relationships, negotiate contracts and get their products in front of payers and pharmacy benefit managers who will clear the way for patient treatment coverage. Challenges Facing…